Appropriate patient instructions can reduce prostate motion

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Graf, Reinhold ^a   Boehmer, Dirk ^a   Nadobny, Jacek ^a   Budach, Volker ^a   Wust, Peter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Fiducial markers; Patient instruction; Prostate motion

Indexed keywords

ARTICLE; ARTIFACT; BLADDER FILLING; DEFECATION; FIDUCIAL MARKER; HUMAN; MALE; PATIENT EDUCATION; PATIENT POSITIONING; PELVIC GIRDLE; PROSTATE; PROSTATE INTERFRACTION MOTION ERROR;

FIDUCIAL MARKERS; HUMANS; MALE; MOVEMENT; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PROGNOSIS; PROSTATIC NEOPLASMS; PROSTHESES AND IMPLANTS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 84864402380     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-125     Document Type: Article

References (17)

1. Zietman AL, DeSilvio ML, Slater JD, et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. J Am Med Assoc 2005, 294:1233-1239.
2. Peeters STH, Heemsbergen WD, Koper PCM, et al. Dose-response in radiotherapy for lacalized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 2006, 24:1190-1196.
3. Kupelian PA, Potters L, Khuntia D, Ciezki JP, Reddy CA, Reuther AM, Carlson TP, Klein EA. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys 2004, 58(1):25-33. 10.1016/S0360-3016(03)00784-3, 14697417.
4. Peeters ST, Heemsbergen WD, van Putten WL, Slot A, Tabak H, Mens JW, Lebesque JV, Koper PC. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys 2005, 61(4):1019-1034. 10.1016/j.ijrobp.2004.07.715, 15752881.
5. Martin JM, Bayley A, Bristow R, Chung P, Gospodarowicz M, Menard C, Milosevic M, Rosewall T, Warde PR, Catton CN. Image guided dose escalated prostate radiotherapy: still room to improve. Radiat Oncol 2009, 4:50. 10.1186/1748-717X-4-50, 2777178, 19887007.
6. Rochet N, Sterzing F, Jensen A, Dinkel J, Herfarth K, Schubert K, Eichbaum M, Schneeweiss A, Sohn C, Debus J, Harms W. Helical tomotherapy as a new treatment technique for whole abdominal irradiation. Strahlenther Onkol 2008, 184(3):145-149. 10.1007/s00066-008-1772-z, 18330510.
7. Barney BM, Lee RJ, Handrahan D, Welsh KT, Cook JT, Sause WT. Image-guided radiotherapy (IGRT) for prostate cancer comparing kV imaging of fiducial markers with cone beam computed tomography (CBCT). Int J Radiat Oncol Biol Phys 2011, 80(1):301-305. 10.1016/j.ijrobp.2010.06.007, 20864274.
8. Van Herk M. Errors and margins in radiotherapy. Semin Radiat Oncol 2004, 14(1):52-64. 10.1053/j.semradonc.2003.10.003, 14752733.
9. Heemsbergen WD, Hoogeman MS, Witte MG, Peeters ST, Incrocci L, Lebesque JV. Increased risk of biochemical and clinical failure for prostate patients with a large rectum at radiotherapy planning: results from the Dutch trial of 68 Gy versus 78 Gy. Int J Radiat Oncol Biol Phys 2007, 67:1418-1424. 10.1016/j.ijrobp.2006.11.014, 17241751.
10. Engels B, Soete G, Verellen D, Storme G. Conformal arc radiotherapy for prostate cancer: increased biochemical failure in patients with distended rectum on the planning computed tomogram despite image guidance by implanted markers. Int J Radiat Oncol Biol Phys 2009, 74:388-391. 10.1016/j.ijrobp.2008.08.007, 19056185.
11. Kupelian PA, Willoughby TR, Reddy CA, Klein EA, Mahadevan A. Impact of image guidance on outcomes after external beam radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008, 70:1146-1150. 10.1016/j.ijrobp.2007.08.003, 17919834.
12. Graf R, Wust P, Budach V, Boehmer D. Potentials of on-line repositioning based on implanted fiducial markers and electronic portal imaging in prostate cancer radiotherapy. Radiat Oncol 2009, 4:13. 10.1186/1748-717X-4-13, 2683853, 19397824.
13. Soete G, De Cock M, Verellen D, et al. X-ray-assisted positioning of patients treated by conformal arc radiotherapy for prostate cancer: Comparison of setup accuracy using implanted markers versus bony structures. Int J Radiat Oncol Biol Phys 2007, 67(3):823-827. 10.1016/j.ijrobp.2006.09.041, 17197124.
14. Tanyi JA, Tongming HE, Summers PA, et al. Assessment of planning target volume margins for intensity-modulated radiotherapy of the prostate gland: role of daily inter- and intrafraction motion. Int J Radiat Oncol Biol Phys 2010, 78(5):1579-1585. 10.1016/j.ijrobp.2010.02.001, 20472357.
15. Smitsmans MH, Pos FJ, de Bois J, Heemsbergen WD, Sonke JJ, Lebesque JV, van Herk M. The influence of a dietary protocol on cone beam CT-guided radiotherapy for prostate cancer patients. Int J Radiat Oncol Biol Phys 2008, 71:1279-1286. 10.1016/j.ijrobp.2008.03.036, 18572088.
16. Kupelian PA, Willoughby TR, Meeks SL, et al. Intraprostatic fiducials for localization of the prostate gland: Monitoring intermarker distances during radiation therapy to test for marker stability. Int J Radiat Oncol Biol Phys 2005, 62:1291-1296. 10.1016/j.ijrobp.2005.01.005, 16029784.
17. Skarsgard D, Cadman P, El-Gayed A, et al. Planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers. Radiat Oncol 2010, 5:52. 10.1186/1748-717X-5-52, 2896366, 20537161.